Initially developed to model lethal SARS-CoV infection, the K18-hACE2 mouse model expresses hACE2 under the control of the epithelial cell cytokeratin-18 (K18) promoter, allowing for high-level expression of hACE2 in epithelial cells [10]. This evidence concerns the gene KRT18 and severe acute respiratory syndrome.